Sionna Therapeutics (SION) Operating Expenses (2024 - 2026)
Sionna Therapeutics (SION) posted Operating Expenses of $29.6 million for Q1 2026, up 25.36% sequentially from $23.6 million in Q4 2025, and up 50.56% YoY from $19.7 million in Q1 2025.
Sionna Therapeutics (SION) Operating Expenses (2024 - 2026) Analysis & Trends
Sionna Therapeutics has reported Operating Expenses for 3 years, with the latest figure at $29.6 million in Q1 2026.
- Quarterly Operating Expenses rose 50.56% year-over-year to $29.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98.9 million (up 28.36% YoY) and the FY2025 annual result came in at $89.0 million, up 26.12% from the prior year.
- Operating Expenses advanced to $29.6 million in Q1 2026 per SION's latest filing, from $23.6 million in the prior quarter.
- Over five years, Operating Expenses peaked at $29.6 million in Q1 2026 and troughed at $11.3 million in Q2 2024.
- A 3-year average of $21.0 million and a median of $21.9 million in 2025 frame the typical range for Operating Expenses.
- The widest YoY moves for Operating Expenses: up 94.0% in 2025, down 14.93% in 2025.
- Over 3 years, Operating Expenses stood at $18.1 million in 2024, then jumped by 30.22% to $23.6 million in 2025, then rose by 25.36% to $29.6 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $29.6 million, $23.6 million, and $23.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Sionna Therapeutics | 291.76 Mn | 291.76 Mn | - | 32.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.47 Mn |
| Mar 31, 2026 | 29.60 Mn |
| Dec 31, 2025 | 23.61 Mn |
| Sep 30, 2025 | 23.81 Mn |
| Jun 30, 2025 | 21.91 Mn |
| Mar 31, 2025 | 19.66 Mn |
| Dec 31, 2024 | 18.13 Mn |
| Sep 30, 2024 | 27.98 Mn |
| Jun 30, 2024 | 11.29 Mn |
| Mar 31, 2024 | 13.15 Mn |